Stay updated on the latest breakthroughs in biotechnology. From advancements in gene editing technologies like CRISPR to developments in cell and gene therapies, explore how biotech is driving medical innovation and transforming patient care.
The FDA has imposed significant restrictions on Bluebird Bio’s Skysona gene therapy following the emergence of concerning cancer risks in treated patients. This regulatory action
The FDA has granted approval to Hernexeos, a breakthrough targeted therapy for advanced lung cancer, marking a significant milestone in oncology treatment options for patients
Strand Therapeutics has raised an impressive $153 million in funding to advance its pioneering programmable mRNA cancer therapy platform, with backing from pharmaceutical giants Amgen
Jazz Pharmaceuticals has achieved a groundbreaking milestone in pediatric oncology with the FDA approval of Modeyso (vorasidenib), marking the first systemic treatment specifically approved for
Eli Lilly’s highly anticipated oral obesity treatment orforglipron delivered solid but underwhelming results in its Phase 3 trial, triggering a dramatic market reaction that wiped
Strategic Leaning in a Capital-Conscious Biotech Environment Flagship Pioneering’s Alltrna has made the unusual decision to trim its workforce ahead of dosing its first patient
Strategic Pipeline Focus as Competitive Pressures Mount Against Lilly Novo Nordisk’s recent decision to drop two obesity drug candidates—another GLP-1/GIP co-agonist and CB1 receptor as
How the GAO’s Illegal Withholding Decision Changes NIH Leverage Over Grantees The Government Accountability Office’s (GAO) bombshell ruling that the National Institutes of Health violated
How Upcoming Tariffs Could Reshape Drug Pricing, Global Manufacturing, and Supply Chains President Trump’s latest threat to impose tariffs reaching 250% on pharmaceutical imports represents
Key Takeaways: Neurodegenerative diseases like Alzheimer’s, Parkinson’s, and ALS remain critical unmet needs in medicine. Biotech innovations, from gene therapies to biomarkers, are paving the
